Literature DB >> 10199526

Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs.

V Wenzel1, K H Lindner, A W Prengel, C Maier, W Voelckel, K G Lurie, H U Strohmenger.   

Abstract

OBJECTIVE: Although a benefit of vasopressin when compared with epinephrine was shown during cardiopulmonary resuscitation (CPR) after a short duration of ventricular fibrillation cardiac arrest, the effect of vasopressin during prolonged cardiac arrest with pulseless electrical activity is currently unknown.
DESIGN: Prospective, randomized laboratory investigation using an established porcine model with instrumentation for measurement of hemodynamic variables, vital organ blood flow, blood gases, and return of spontaneous circulation.
SETTING: University hospital laboratory.
SUBJECTS: Eighteen domestic pigs.
INTERVENTIONS: After 15 mins of cardiac arrest and 3 mins of chest compressions, 18 animals were randomly treated with either 0.8 units/kg vasopressin (n = 9) or 200 microg/kg epinephrine (n = 9).
MEASUREMENTS AND MAIN RESULTS: Compared with epinephrine, vasopressin resulted, at both 90 secs and 5 mins after drug administration, in significantly higher (p < .05) median (25th-75th percentiles) left ventricular myocardial blood flow (120 [range, 96-193] vs. 54 [range, 11-92] and 56 [range, 41-80] vs. 21 [range, 11-40] mL/min/100 g, respectively) and total cerebral blood flow (85 [78-102] vs. 24 [18-41] and 50 [44-52] vs. 8 [5-23] mL/min/100 g, respectively). Spontaneous circulation was restored in eight of nine animals in the vasopressin group and in one of nine animals in the epinephrine group (p = .003).
CONCLUSIONS: Compared with a maximum dose of epinephrine, vasopressin significantly increased left ventricular myocardial and total cerebral blood flow during CPR and return of spontaneous circulation in a porcine model of prolonged cardiac arrest with postcountershock pulseless electrical activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199526     DOI: 10.1097/00003246-199903000-00022

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study.

Authors:  Georgios Papadopoulos; Eleni Sintou; Stavros Siminelakis; Efstratios Koletsis; Nikolaos G Baikoussis; Efstratios Apostolakis
Journal:  J Cardiothorac Surg       Date:  2010-03-28       Impact factor: 1.637

2.  Thrombolytic-Enhanced Extracorporeal Cardiopulmonary Resuscitation After Prolonged Cardiac Arrest.

Authors:  Elena Spinelli; Ryan P Davis; Xiaodan Ren; Parth S Sheth; Trevor R Tooley; Amit Iyengar; Brandon Sowell; Gabe E Owens; Martin L Bocks; Teresa L Jacobs; Lynda J Yang; William C Stacey; Robert H Bartlett; Alvaro Rojas-Peña; Robert W Neumar
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

3.  Goal-directed cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest in the emergency Department: A feasibility study.

Authors:  Byron C Drumheller; Joseph Pinizzotto; Ryan C Overberger; Erin E Sabolick
Journal:  Resusc Plus       Date:  2021-08-25

Review 4. 

Authors:  J P Nolan; C D Deakin; J Soar; B W Böttiger; G Smith; M Baubin; B Dirks; V Wenzel
Journal:  Notf Rett Med       Date:  2006-02-01       Impact factor: 0.826

5.  Vasopressin treatment of verapamil toxicity in the porcine model.

Authors:  J Dave Barry; Dave Durkovich; Lee Cantrell; William Richardson; Tri Tong; Steve Offerman; Richard F Clark; David A Tanen; Saralyn Williams
Journal:  J Med Toxicol       Date:  2005-12

Review 6.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

Review 7.  Is there still a place for vasopressors in the treatment of cardiac arrest?

Authors:  Claudio Sandroni; Fabio Cavallaro; Massimo Antonelli
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

8.  Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study.

Authors:  Stefek Grmec; Stefan Mally
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

9.  Vasopressin decreases neuronal apoptosis during cardiopulmonary resuscitation.

Authors:  Chi Ma; Zhe Zhu; Xu Wang; Gang Zhao; Xiaoliang Liu; Rui Li
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.